Gay, bisexual and transgendered individuals (GBT) have much higher rates of HIV infection in the United States than their heterosexual counterparts [1-5]. While accounting for
only 2% of the US population, MSM (including bisexual and MSM/bisexual injection drug users) make up 58.32% of persons with HIV in the country and there continues to be a trend toward increase in this population and a trend toward decrease in the heterosexual population [6]. There is much less data on transgender individuals’ HIV disparities, however two studies found elevated rates among the trans-female population (assigned male at birth but whose gender identity is that of a woman) [4,5]. While behavioral prevention intervention has been effective, more is needed to prevent HIV infection among these populations. Pre-exposure prophylaxis (PrEP) is considered an effective biomedical approach for HIV prevention and when used consistently, significantly decreases HIV infection rates.

PreExposure Prophylaxis

Training for Health Care Providers in the Administration of PrEP

2017 National CFAR Meeting ESI Abstract

PrEP Research Project